Stream Biomedical
Houston, US · Delaware corporation · 1 known investors
Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems. Its lead program targets Alzheimer's disease and related dementias, with potential use in stroke, traumatic brain injury, and other neurological conditions.
Founders & leadership
HD
H. Davis AdkissonChief Scientific Officer
CG
Chris GarabedianNamed on SEC filing
WS
William SchwietermanBoard of Directors
FC
Fred CalloriNamed on SEC filing
BC
Bryan ClossenDirector of Translational Programs
SF
Seth Fisher
Board
AD
Investors · 1
Reported raises · per SEC filings
Form D private placements$21.5M disclosed across 1 round · 2021
▶$21.5MraisedJan 2022 · 11 investors · PharmaceuticalsRule 506(b)
▶$21.5MraisedJan 2022 · 11 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Chris GarabedianDirector
- Amanda De La GarzaDirector
- William SchwietermanExecutive Officer, Director
- Fred CalloriDirector
- Offering amount
- $21.5M
- Amount sold
- $21.5M
- Minimum investment
- $50K
- First sale
- Dec 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlap
▶︎ STRM.BIO3 shared keywordsSTRM.BIO develops a gene therapy delivery platform based on megakaryocyte-derived extracellular vesicles (STRM MVs) that target and deliver genetic cargoes preferentially to bone marrow and hematopoietic stem cells. The platform enables in vivo genetic medicines with an initial focus on rare hematological diseases and CAR-T therapies, supporting approaches such as gene editing, RNA therapeutics, and immune cell engineering.
Midstream Health3 shared keywordsMidstream is an AI-powered financial action platform for health systems that provides real-time visibility into operations and enables proactive decision-making. The platform addresses delayed financial reporting by translating complex health system data into actionable insights for finance and operations teams.
Companies competing with Stream Biomedical for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Stream Biomedical do?
- Stream Biomedical is a clinical-stage biotechnology company developing LG3, a biologic derived from a natural repair protein intended to protect and restore the brain by activating its repair systems. Its lead program targets Alzheimer's disease and related dementias, with potential use in stroke, traumatic brain injury, and other neurological conditions.
- Who are Stream Biomedical's investors?
- Stream Biomedical's investors include Bios Partners.
- How much funding has Stream Biomedical raised?
- Stream Biomedical has disclosed $21.5M raised across 1 round.
- Where is Stream Biomedical headquartered?
- Stream Biomedical is headquartered in Houston, US.